TCRX Earnings

Quarterly EPS
$-0.25
Q3 2024
$-0.30
Q4 2024
$-0.26
Q1 2025
$-0.28
Q2 2025
$-0.28
Q3 2025
$-0.18
Q4 2025
$-0.22
Q1 2026
$-0.23
Q2 2026
Latest Revenue1.1M
Latest Net Income-30359000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.231.1M-30359000-65.8%+17.9%
Q1 2026-$0.22982.0K-28666000-54.8%+15.4%
Q4 2025-$0.182.6M-22977000+286.0%+40.0%
Q3 2025-$0.282.5M-35710000+139.4%-12.0%
Q2 2025-$0.283.1M-36952000+473.9%+0.0%
Q1 2025-$0.262.2M-34127000+283.6%+18.8%
Q4 2024-$0.30665.0K-35809000-90.8%-50.0%
Q3 2024-$0.251.0M-29887000-73.0%-4.2%
Q2 2024-$0.28536.0K-31661000
Q1 2024-$0.32566.0K-30142000
Q4 2023-$0.207.2M-19613000
Q3 2023-$0.243.9M-22997000
TScan Therapeutics (TCRX) — Earnings